Literature DB >> 11288108

Cytokines influence mRNA expression of cytochrome P450 3A4 and MDRI in intestinal cells.

P M Bertilsson1, P Olsson, K E Magnusson.   

Abstract

Inflammation and infection may have the potential to increase the bioavailability of drugs. This effect could be because of a reduced metabolism of xenobiotics in the liver and/or the intestines, or because of alterations in small intestinal permeability, mucosal flow, and expression of drug efflux transporters such as P-glycoprotein (Pgp). To assess the impact on intestinal epithelium of some proinflammatory cytokines and macrophages on permeability and mRNA expression of CYP3A4 and MDRI (multidrug resistance, coding for Pgp), we used the Caco-2 cell line as a model. Exposure to proinflammatory cytokines and macrophages decreased the mRNA expression of CYP3A4 and increased the expression of MDR1 mRNA in the Caco-2 cells. In parallel, the cell layer permeability, as measured by sodium fluorescein flux, increased for all cytokine and macrophage treatments, whereas the effect on transepithelial electrical resistance (TEER) varied. Our findings suggest that inflammation and infection trigger several different cellular responses that may affect drug bioavailability; that is hampered CYP3A4 expression, increased permeability of the epithelial cell layer, and enhanced Pgp-mediated counteractive transport. Copyright 2001 Wiley-Liss, Inc. and the American Pharmaceutical Association.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11288108     DOI: 10.1002/1520-6017(200105)90:5<638::aid-jps1020>3.0.co;2-l

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  17 in total

Review 1.  Small bowel review: Normal physiology, part 2.

Authors:  Alan B R Thomson; Laurie Drozdowski; Claudiu Iordache; Ben K A Thomson; Severine Vermeire; M Tom Clandinin; Gary Wild
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

2.  Cytokine regulation of OCTN2 expression and activity in small and large intestine.

Authors:  Mikihiro Fujiya; Yuhei Inaba; Mark W Musch; Shien Hu; Yutaka Kohgo; Eugene B Chang
Journal:  Inflamm Bowel Dis       Date:  2010-08-18       Impact factor: 5.325

3.  Impact of interleukin-10 gene polymorphisms on tacrolimus dosing requirements in Chinese liver transplant patients during the early posttransplantation period.

Authors:  Xiaoqing Zhang; Zhaowen Wang; Junwei Fan; Gaolin Liu; Zhihai Peng
Journal:  Eur J Clin Pharmacol       Date:  2011-02-26       Impact factor: 2.953

4.  Associations of ABCB1 3435C>T and IL-10-1082G>A polymorphisms with long-term sirolimus dose requirements in renal transplant patients.

Authors:  Wai-Johnn Sam; Christine E Chamberlain; Su-Jun Lee; Joyce A Goldstein; Douglas A Hale; Roslyn B Mannon; Allan D Kirk; Yuen Yi Hon
Journal:  Transplantation       Date:  2011-12-27       Impact factor: 4.939

5.  Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium.

Authors:  Raymond Evers; Micheline Piquette-Miller; Joseph W Polli; Frans G M Russel; Jason A Sprowl; Kimio Tohyama; Joseph A Ware; Saskia N de Wildt; Wen Xie; Kim L R Brouwer
Journal:  Clin Pharmacol Ther       Date:  2018-07-12       Impact factor: 6.875

6.  Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humans.

Authors:  Christian Joukhadar; Heino Stass; Ulrike Müller-Zellenberg; Edith Lackner; Florian Kovar; Erich Minar; Markus Müller
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

Review 7.  Pharmacology of morphine in obese patients: clinical implications.

Authors:  Célia Lloret Linares; Xavier Declèves; Jean Michel Oppert; Arnaud Basdevant; Karine Clement; Christophe Bardin; Jean Michel Scherrmann; Jean Pierre Lepine; Jean François Bergmann; Stéphane Mouly
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

8.  Interleukin-1 beta and tumor necrosis factor-alpha increase ABCG2 expression in MCF-7 breast carcinoma cell line and its mitoxantrone-resistant derivative, MCF-7/MX.

Authors:  Fatemeh Mosaffa; Hermann Lage; Jalil Tavakol Afshari; Javad Behravan
Journal:  Inflamm Res       Date:  2009-03-31       Impact factor: 4.575

9.  Global analysis of the eukaryotic pathways and networks regulated by Salmonella typhimurium in mouse intestinal infection in vivo.

Authors:  Xingyin Liu; Rong Lu; Yinglin Xia; Jun Sun
Journal:  BMC Genomics       Date:  2010-12-20       Impact factor: 3.969

Review 10.  Personalization of the immunosuppressive treatment in renal transplant recipients: the great challenge in "omics" medicine.

Authors:  Gianluigi Zaza; Simona Granata; Paola Tomei; Alessandra Dalla Gassa; Antonio Lupo
Journal:  Int J Mol Sci       Date:  2015-02-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.